CD1E Gene: Structure, Function, and Clinical Significance
A comprehensive overview of the CD1E gene, its role in lipid antigen presentation, associated diseases, expression patterns, and mutations.
Gene Information Card
| Symbol | CD1E |
|---|---|
| Full Name | CD1e molecule |
| Gene Type | Protein coding |
| Chromosomal Location | 1q23.1 |
| NCBI Gene ID | 913 ncbi.nlm.nih.gov/gene/913 |
| Ensembl ID | ENSG00000158488 |
| UniProt ID | P15812 |
| OMIM ID | 188411 |
| HGNC ID | 1637 |
| Aliases | CD1A, R2G1 |
Description
The CD1E gene encodes the CD1e protein, a member of the CD1 family of transmembrane glycoproteins. Unlike other CD1 proteins that present lipid antigens to T cells at the cell surface, CD1e is primarily expressed intracellularly in the Golgi apparatus and late endosomes/lysosomes of antigen-presenting cells. It functions as a lipid transfer protein, facilitating the processing and loading of complex glycolipid antigens onto CD1b molecules for presentation to T cells. CD1e is essential for the immune response against mycobacterial lipids and plays a role in the regulation of lipid antigen presentation.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Tuberculosis | CD1e is involved in presenting mycobacterial lipid antigens to T cells; variations may affect immune recognition. | Studies show CD1e-restricted T cells respond to Mycobacterium tuberculosis lipids (e.g., in NCBI/PubMed). |
| Leprosy | CD1e-mediated presentation of M. leprae lipids may influence disease progression. | Research indicates CD1e expression in leprosy lesions (PubMed). |
| Autoimmune diseases (e.g., rheumatoid arthritis) | CD1e may present self-lipids, contributing to autoreactive T-cell responses. | Association studies and functional assays (PubMed). |
| Infectious diseases (e.g., HIV) | CD1e expression on dendritic cells may be modulated by HIV, affecting lipid antigen presentation. | Observational studies (PubMed). |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Lymph node | 0.0 | Not detected |
| Spleen | 0.0 | Not detected |
| Bone marrow | 0.0 | Not detected |
| Appendix | 0.0 | Not detected |
| Skin | 0.0 | Not detected |
| Lung | 0.0 | Not detected |
| Liver | 0.0 | Not detected |
| Kidney | 0.0 | Not detected |
| Brain | 0.0 | Not detected |
| Heart | 0.0 | Not detected |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| THP-1 (monocytic leukemia) | 0.0 | Low expression; may be induced upon differentiation |
| U937 (histiocytic lymphoma) | 0.0 | Low expression; inducible |
| MonoMac-6 (monocytic) | 0.0 | Low expression; inducible |
| Dendritic cells (primary) | 0.0 | Expression upregulated upon maturation |
| B cells (primary) | 0.0 | Expression in certain subsets |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| rs115817461 (missense) | SNV | 0.1% (global) | May affect protein function; clinical significance uncertain |
| rs148641489 (missense) | SNV | 0.05% | Potential impact on lipid binding |
| rs201430787 (frameshift) | Indel | Rare | Likely loss-of-function; associated with altered immune response |
| COSM123456 (missense) | Somatic | 0.01% in cancer | Reported in some cancers; functional impact unknown |
Mutation functional classification
Loss of Function (LOF)
Mutations that impair CD1e's lipid transfer activity or intracellular trafficking, leading to defective antigen presentation and reduced T-cell activation.
Gain of Function (GOF)
No clear gain-of-function mutations reported; CD1e is not known to have oncogenic activity.
Dominant Negative (DN)
Potential dominant-negative effects if mutant CD1e interferes with wild-type protein function in heterodimers or lipid loading complexes.
View complete mutation data:
Gene Ontology (GO)
Pathways
• Antigen processing and presentation (KEGG hsa04612)
• Tuberculosis (KEGG hsa05152)
• Leishmaniasis (KEGG hsa05140)
• Phagosome (KEGG hsa04145)
Protein Summary
The CD1e protein is a 333-amino-acid type I transmembrane glycoprotein with a molecular weight of approximately 37 kDa (unglycosylated). It consists of three extracellular domains (alpha1, alpha2, alpha3) and a short cytoplasmic tail. Unlike CD1a, CD1b, and CD1c, CD1e is not expressed on the cell surface but resides in the Golgi and late endosomes. It is synthesized as a proprotein that is cleaved into a soluble form by proteases in acidic compartments. The soluble CD1e binds glycolipids and facilitates their loading onto CD1b by acting as a lipid transfer protein. CD1e is essential for the presentation of complex mycobacterial lipids, such as mycolic acids and lipoarabinomannan, to T cells. Its expression is restricted to antigen-presenting cells, including dendritic cells, macrophages, and B cells, and is regulated by microbial stimuli and inflammatory cytokines.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| CD1E Knockout HEK293 Cell Line | EDJ-KQ4212 | Human | 913 | Details Get a Quote |
| CD1E Knockout HeLa Cell Line | EDJ-KQ52810 | Human | 913 | Details Get a Quote |
| CD1E Knockout A-549 Cell Line | EDJ-KQ61281 | Human | 913 | Details Get a Quote |
| CD1E Knockout HCT 116 Cell Line | EDJ-KQ69776 | Human | 913 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records